Abstract
EpilepsiaVolume 46, Issue s8 p. 273-273 Free Access Pediatric State of the Art Symposium: Seizures and Epilepsy Complicating Medical Conditions in Childhood 7:30 p.m.–9:30 p.m. First published: 19 October 2005 https://doi.org/10.1111/j.1528-1167.2005.460801_28.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract 1 Dennis J. Dlugos, 2 Mary L. Zupanc, 1 Robert R. Clancy, 3 Anna Janss, and 4 Benjamin Eidelman ( 1 Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA ; 2 Department of Neurology, Children's Hospital of Wisconsin, Milwaukee, WI ; 3 Department of Neurology, Emory University School of Medicine, Atlanta, GA ; and 4 Department of Neurology, Mayo Clinic, Jacksonville, FL ) This symposium will address advances in clinical management and translational research regarding acute provoked seizures and chronic epilepsy in children with complex medical conditions, such as congenital heart disease, oncological disorders, and organ transplantation. These medical conditions are all complicated by acute provoked seizures and chronic epilepsy, involve treatment with medications with complex interactions with anti-epileptic drugs, and provide opportunities for translational research. The goals of the symposium are: 1) Understand the etiology, pathophysiology and treatment of acute provoked seizures in children with congenital heart disease, CNS and non-CNS neoplasms, and organ transplantation. 2) Understand the etiology, pathophysiology and treatment of chronic epilepsy in these patients, including interactions between anti-epileptic drugs and anti-arrhythmic drugs, chemotherapeutic agents, and immunosuppressive agents. 3) Recognize opportunities for translational research in this area, including neuro-protection, pharmacology and immunology. Volume46, Issues8October 2005Pages 273-273 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
